lithium carbonate has been researched along with Refractory Depression in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Rybakowski, JK | 1 |
| Adli, M; Behr, J; Berger, M; Bräunig, P; Bschor, T; Buspavanich, P; de Millas, W; Heinz, A; Hellweg, R; Hindinger, C; Jockers-Scherübl, MC; Rentzsch, J; Richter, C; Ricken, R; Schlattmann, P; Stamm, T | 1 |
| Adli, M; Borgwardt, S; Bschor, T; Gaus, S; Heinz, A; Hellweg, R; Koehler, S; Krusche, E; Lang, UE; Lange, C; Nase, S; Rapp, MA; Richter, C; Ricken, R; Stamm, TJ; Steinacher, B | 1 |
| Muneoka, K; Sato, K; Shirayama, Y; Suzuki, M; Takahashi, M; Tsuruoka, Y | 1 |
| Bschor, T; Erbe, S; Gutwinski, S | 1 |
| Alda, M; Calkin, C | 1 |
| Cryan, JF; Dinan, TG; O'Leary, OF; Zandy, S | 1 |
3 review(s) available for lithium carbonate and Refractory Depression
| Article | Year |
|---|---|
Lithium treatment in the era of personalized medicine.
Topics: Antimanic Agents; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Humans; Lithium Carbonate; Mood Disorders; Precision Medicine; Suicide Prevention | 2021 |
[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium Carbonate; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2012 |
Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium.
Topics: Antimanic Agents; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Diagnosis, Differential; Drug Substitution; Guideline Adherence; Humans; Lithium Carbonate; Long-Term Care; Practice Guidelines as Topic; Secondary Prevention | 2012 |
1 trial(s) available for lithium carbonate and Refractory Depression
| Article | Year |
|---|---|
Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Topics: Acute Disease; Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome | 2013 |
3 other study(ies) available for lithium carbonate and Refractory Depression
| Article | Year |
|---|---|
Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cohort Studies; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2019 |
Personality traits as predictors for the outcome of lithium augmentation in treatment-resistant depression.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Character; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Personality Inventory; Psychometrics; Treatment Outcome | 2014 |
Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.
Topics: Animals; Cell Proliferation; Depressive Disorder, Treatment-Resistant; Desipramine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hippocampus; Lithium Carbonate; Male; Mice; Mice, Inbred BALB C; Treatment Outcome | 2013 |